167 related articles for article (PubMed ID: 21161346)
1. Role of thymic stromal lymphopoietin (TSLP) in palifermin-mediated immune modulation and protection from acute murine graft-versus-host disease.
Ellison CA; Lissitsyn YV; Packiasamy JA; Leonard WJ; Gartner JG
J Clin Immunol; 2011 Jun; 31(3):406-13. PubMed ID: 21161346
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulatory effects of palifermin (recombinant human keratinocyte growth factor) in an SLE-like model of chronic graft-versus-host disease.
Ellison CA; Lissitsyn YV; Gheorghiu I; Gartner JG
Scand J Immunol; 2012 Jan; 75(1):69-76. PubMed ID: 21916922
[TBL] [Abstract][Full Text] [Related]
3. Palifermin mediates immunoregulatory effects in addition to its cytoprotective effects in mice with acute graft-versus-host disease.
Ellison CA; Makar BM; Wiseman JM; Gheorghiu I; Taniguchi M; Gartner JG
J Clin Immunol; 2008 Sep; 28(5):600-15. PubMed ID: 18592360
[TBL] [Abstract][Full Text] [Related]
4. Effect of palifermin in a murine model of graft-versus-host disease (GVHD) associated with Th2 cytokine production, autoantibody production, and glomerulonephritis.
Ellison CA; Gibson IW; Hayglass KT; Gartner JG
J Clin Immunol; 2006 Sep; 26(5):485-94. PubMed ID: 16952010
[TBL] [Abstract][Full Text] [Related]
5. Antagonistic effect of the inflammasome on thymic stromal lymphopoietin expression in the skin.
Schuepbach-Mallepell S; Philippe V; Brüggen MC; Watanabe H; Roques S; Baldeschi C; Gaide O
J Allergy Clin Immunol; 2013 Dec; 132(6):1348-57. PubMed ID: 23953709
[TBL] [Abstract][Full Text] [Related]
6. TSLPR deficiency attenuates atherosclerotic lesion development associated with the inhibition of TH17 cells and the promotion of regulator T cells in ApoE-deficient mice.
Wu C; He S; Peng Y; Kushwaha KK; Lin J; Dong J; Wang B; Lin J; Shan S; Liu J; Huang K; Li D
J Mol Cell Cardiol; 2014 Nov; 76():33-45. PubMed ID: 25117469
[TBL] [Abstract][Full Text] [Related]
7. Thymic stromal lymphopoietin is a key cytokine for the immunomodulation of atherogenesis with Freund's adjuvant.
Steinmetz M; Laurans L; Nordsiek S; Weiß L; van der Veken B; Ponnuswamy P; Esposito B; Vandestienne M; Giraud A; Göbbel C; Steffen E; Radecke T; Potteaux S; Nickenig G; Rassaf T; Tedgui A; Mallat Z
J Cell Mol Med; 2020 May; 24(10):5731-5739. PubMed ID: 32285594
[TBL] [Abstract][Full Text] [Related]
8. Thymic stromal lymphopoietin plays divergent roles in murine models of atopic and nonatopic airway inflammation.
Yadava K; Massacand J; Mosconi I; Nicod LP; Harris NL; Marsland BJ
Allergy; 2014 Oct; 69(10):1333-42. PubMed ID: 24961817
[TBL] [Abstract][Full Text] [Related]
9. Thymic stromal lymphopoietin signaling in CD4(+) T cells is required for TH2 memory.
Wang Q; Du J; Zhu J; Yang X; Zhou B
J Allergy Clin Immunol; 2015 Mar; 135(3):781-91.e3. PubMed ID: 25441291
[TBL] [Abstract][Full Text] [Related]
10. Thymic stromal lymphopoietin receptor blockade reduces allergic inflammation in a cynomolgus monkey model of asthma.
Cheng DT; Ma C; Niewoehner J; Dahl M; Tsai A; Zhang J; Gonsiorek W; Apparsundaram S; Pashine A; Ravindran P; Jung J; Hang J; Allard J; Bitter H; Tribouley C; Narula S; Wilson S; Fuentes ME
J Allergy Clin Immunol; 2013 Aug; 132(2):455-62. PubMed ID: 23810153
[TBL] [Abstract][Full Text] [Related]
11. Blockage of thymic stromal lymphopoietin signaling improves acute lung injury in mice by regulating pulmonary dendritic cells.
Pan G; Liang Y; Lu L; Chen X; Wang M; Wang L; Yan C; Zhang W
Int J Clin Exp Pathol; 2015; 8(9):10698-706. PubMed ID: 26617780
[TBL] [Abstract][Full Text] [Related]
12. A role for thymic stromal lymphopoietin in CD4(+) T cell development.
Al-Shami A; Spolski R; Kelly J; Fry T; Schwartzberg PL; Pandey A; Mackall CL; Leonard WJ
J Exp Med; 2004 Jul; 200(2):159-68. PubMed ID: 15263024
[TBL] [Abstract][Full Text] [Related]
13. Disruption of the TSLP-TSLPR-LAP signaling between epithelial and dendritic cells through hyperlipidemia contributes to regulatory T-Cell defects in atherosclerotic mice.
Yu K; Dong Q; Mao X; Meng K; Zhao X; Ji Q; Wu B; Zhong Y; Zhu Z; Liu Y; Zhang W; Tony H; Shi H; Zeng Q
Atherosclerosis; 2015 Feb; 238(2):278-88. PubMed ID: 25544178
[TBL] [Abstract][Full Text] [Related]
14. Expression and Regulation of Thymic Stromal Lymphopoietin and Thymic Stromal Lymphopoietin Receptor Heterocomplex in the Innate-Adaptive Immunity of Pediatric Asthma.
Lin SC; Cheng FY; Liu JJ; Ye YL
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29670037
[TBL] [Abstract][Full Text] [Related]
15. Critical proinflammatory role of thymic stromal lymphopoietin and its receptor in experimental autoimmune arthritis.
Hartgring SA; Willis CR; Dean CE; Broere F; van Eden W; Bijlsma JW; Lafeber FP; van Roon JA
Arthritis Rheum; 2011 Jul; 63(7):1878-87. PubMed ID: 21391201
[TBL] [Abstract][Full Text] [Related]
16. Regulation of helminth-induced Th2 responses by thymic stromal lymphopoietin.
Ramalingam TR; Pesce JT; Mentink-Kane MM; Madala S; Cheever AW; Comeau MR; Ziegler SF; Wynn TA
J Immunol; 2009 May; 182(10):6452-9. PubMed ID: 19414799
[TBL] [Abstract][Full Text] [Related]
17. Murine allergic rhinitis and nasal Th2 activation are mediated via TSLP- and IL-33-signaling pathways.
Akasaki S; Matsushita K; Kato Y; Fukuoka A; Iwasaki N; Nakahira M; Fujieda S; Yasuda K; Yoshimoto T
Int Immunol; 2016 Feb; 28(2):65-76. PubMed ID: 26428949
[TBL] [Abstract][Full Text] [Related]
18. Thymic stromal lymphopoietin and thymic stromal lymphopoietin-conditioned dendritic cells induce regulatory T-cell differentiation and protection of NOD mice against diabetes.
Besin G; Gaudreau S; Ménard M; Guindi C; Dupuis G; Amrani A
Diabetes; 2008 Aug; 57(8):2107-17. PubMed ID: 18477807
[TBL] [Abstract][Full Text] [Related]
19. Neutralizing IL-12 during induction of murine acute graft-versus-host disease polarizes the cytokine profile toward a Th2-type alloimmune response and confers long term protection from disease.
Williamson E; Garside P; Bradley JA; More IA; Mowat AM
J Immunol; 1997 Aug; 159(3):1208-15. PubMed ID: 9233615
[TBL] [Abstract][Full Text] [Related]
20. Increased susceptibility to autoimmune gastritis in thymic stromal lymphopoietin receptor-deficient mice.
Nishiura H; Kido M; Aoki N; Iwamoto S; Maruoka R; Ikeda A; Chiba T; Ziegler SF; Watanabe N
J Immunol; 2012 Jan; 188(1):190-7. PubMed ID: 22124119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
